Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States (Q43997694)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States
scientific article

    Statements

    Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States (English)
    Jakob Langer
    Barnaby Hunt
    William J Valentine
    1 April 2013
    237-246

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit